Facial aging
Conditions
Interventions
Sponsors
Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
25 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1) Male or female subjects between the ages of 25 and 50 with different degrees of skin sagging and wrinkles on their faces; 2) Glogau Scale II and III health effects in the treatment area as assessed in the field by independent blind evaluators Try; 3) Can understand and accept the relevant knowledge and risks of percutaneous acupoint electrical stimulation and face acupuncture and sign the informed consent; 4) Can cooperate with long-term satisfaction follow-up survey; 5) In the past six months have not done any facial plastic and cosmetic treatment (such as laser RF injection surgery etc.); 6) did not take the relevant drugs (such as retinoic acid hydroquinone etc.) that affected the test results in the past six months; 7) No skin diseases or other influencing factors on the face.
Exclusion criteria
Exclusion criteria: 1) Subjects who have received permanent or semi-permanent facial implants (e.g. polymethyl methacrylate silicone teflon hydroxyapatite poly-L-lactic acid etc.) anywhere on the face or who plan to have any of these implants during clinical studies; 2) Subjects whose faces received temporary dermal fillers (such as hyaluronic acid fat botox collagen etc.) within 12 months before enrollment or photoelectric treatment such as laser radiofrequency dermification chemical stripping agent ablation or surgical treatment within 12 months before enrollment; 3) Participants who had used OTC anti-wrinkle products or prescription anti-wrinkle drugs for facial wrinkles in the 28 days prior to enrollment or Subjects who plan to use these products during clinical studies; 4) Patients with serious underlying diseases (such as autoimmune diseases cardiac insufficiency etc.) and those suffering from mental diseases; 5) Patients with pacemakers surgical implants artificial heart and lung; 6) People with abnormal coagulation function and taking anticoagulant drugs or cicatricial constitution or local facial infection or subjects who are allergic to lidocaine and related products and have allergic disease; 7) Pregnant women breastfeeding women and minors; 8) Have received other facial treatments within the past year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VISIA data; | — |
Secondary
| Measure | Time frame |
|---|---|
| Glogau scale;FACE-Q scale; | — |
Countries
China
Contacts
Public ContactJing Xu
Chengdu University of Traditional Chinese Medicine
Outcome results
None listed